Italy passed a positive milestone, with 1 million doses of Covid-19 vaccine having been administered just 19 days after the country launched its nationwide vaccination program.
The development was praised by Prime Minister Giuseppe Conte and President Sergio Mattarella, Xinhua news agency reported on Friday.
The key indicator represents a dramatic increase in the pace of distributing the vaccines: it took the country 13 days to give the first 500,000 shots and just 6 to give the next 500,000. According to estimates in the Italian media, the next 500,000 doses could be distributed by late Monday or early Tuesday.
As of January 9, the latest figures available, Italy led Europe in terms of overall Covid-19 vaccine distribution, mostly using the vaccine developed by US pharmaceutical giant Pfizer and German biotechnology company BioNTech. Another vaccine from drug maker Moderna has been approved for use in Italy and started to be distributed earlier this week.
A third vaccine, from Oxford University and AstraZeneca, is the most prominent in a group of three vaccines being evaluated by Italian health officials. AstraZeneca has vowed to provide Italy with 40 million doses of its vaccine by June.
The 1-million-dose milestone does not mean that the same amount of people have been vaccinated since the Pfizer-BioNTech and Moderna vaccines require two doses per person in order to be effective.
The developments came as Italy's coronavirus infection rate starts to inch higher after a mild lull in December. On Friday, the country recorded more than 16,000 new Covid-19 infections and nearly 500 deaths from the virus.
--IANS
int/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU